CVS HEALTH Corp (CVS) stock
CVSNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 12/3012% above fair value
$81.35−4.46 (-5.20%)
Close on Nov 18, 2026Market cap $104.04BP/E 21.6Yield 3.27%
Cvs Health free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Cvs Health's free cash flow for the twelve months ending Jun 30, 2026 was $11.76B, up 146.0% year over year. For fiscal 2025 it was $7.81B, up 23.4% from the year before. Over ten years it grew 2.4% a year on average. The highest annual figure on record is $15.75B in fiscal 2021.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.81B | +23.4% |
| FY2024 | Dec 31, 2024 | $6.33B | -39.1% |
| FY2023 | Dec 31, 2023 | $10.40B | -22.7% |
| FY2022 | Dec 31, 2022 | $13.45B | -14.6% |
| FY2021 | Dec 31, 2021 | $15.75B | +17.3% |
| FY2020 | Dec 31, 2020 | $13.43B | +29.2% |
| FY2019 | Dec 31, 2019 | $10.39B | +52.2% |
| FY2018 | Dec 31, 2018 | $6.83B | +12.1% |
| FY2017 | Dec 31, 2017 | $6.09B | -23.1% |
| FY2016 | Dec 31, 2016 | $7.92B | +28.3% |
| FY2015 | Dec 31, 2015 | $6.17B | +2.8% |
| FY2014 | Dec 31, 2014 | $6.00B | +58.0% |
| FY2013 | Dec 31, 2013 | $3.80B | -18.1% |
| FY2012 | Dec 31, 2012 | $4.64B | +16.5% |
| FY2011 | Dec 31, 2011 | $3.98B | +43.6% |
| FY2010 | Dec 31, 2010 | $2.77B | +86.6% |
| FY2009 | Dec 31, 2009 | $1.49B | -15.8% |
| FY2008 | Dec 31, 2008 | $1.77B | +24.0% |
| FY2007 | Dec 29, 2007 | $1.43B | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $5.65B | +338.3% |
| Q1 FY2026 | Mar 31, 2026 | $3.40B | -10.8% |
| Q4 FY2025 | Dec 31, 2025 | $2.61B | +138.6% |
| Q3 FY2025 | Sep 30, 2025 | $98.00M | – |
| Q2 FY2025 | Jun 30, 2025 | $1.29B | -47.4% |
| Q1 FY2025 | Mar 31, 2025 | $3.81B | -9.2% |
| Q4 FY2024 | Dec 31, 2024 | $1.09B | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.42B | -165.2% |
| Q2 FY2024 | Jun 30, 2024 | $2.45B | -53.9% |
| Q1 FY2024 | Mar 31, 2024 | $4.20B | -35.0% |
| Q4 FY2023 | Dec 31, 2023 | -$3.55B | – |
| Q3 FY2023 | Sep 30, 2023 | $2.17B | -74.6% |
| Q2 FY2023 | Jun 30, 2023 | $5.32B | +5.6% |
| Q1 FY2023 | Mar 31, 2023 | $6.45B | +156.9% |
| Q4 FY2022 | Dec 31, 2022 | -$2.64B | -177.5% |
| Q3 FY2022 | Sep 30, 2022 | $8.54B | +73.9% |
| Q2 FY2022 | Jun 30, 2022 | $5.04B | -6.1% |
| Q1 FY2022 | Mar 31, 2022 | $2.51B | +21.8% |
| Q4 FY2021 | Dec 31, 2021 | $3.41B | +19.4% |
| Q3 FY2021 | Sep 30, 2021 | $4.91B | +266.6% |
| Q2 FY2021 | Jun 30, 2021 | $5.36B | -19.6% |
| Q1 FY2021 | Mar 31, 2021 | $2.06B | -19.5% |
| Q4 FY2020 | Dec 31, 2020 | $2.85B | +38.1% |
| Q3 FY2020 | Sep 30, 2020 | $1.34B | -42.4% |
| Q2 FY2020 | Jun 30, 2020 | $6.67B | +40.0% |
| Q1 FY2020 | Mar 31, 2020 | $2.56B | +108.0% |
| Q4 FY2019 | Dec 31, 2019 | $2.07B | +9.1% |
| Q3 FY2019 | Sep 30, 2019 | $2.33B | +317.8% |
| Q2 FY2019 | Jun 30, 2019 | $4.77B | +90.3% |
| Q1 FY2019 | Mar 31, 2019 | $1.23B | -34.2% |
| Q4 FY2018 | Dec 31, 2018 | $1.89B | – |
| Q3 FY2018 | Sep 30, 2018 | $557.00M | -73.3% |
| Q2 FY2018 | Jun 30, 2018 | $2.50B | +59.7% |
| Q1 FY2018 | Mar 31, 2018 | $1.87B | -39.1% |
| Q4 FY2017 | Dec 31, 2017 | -$642.00M | -142.7% |
| Q3 FY2017 | Sep 30, 2017 | $2.09B | -39.1% |
| Q2 FY2017 | Jun 30, 2017 | $1.57B | – |
| Q1 FY2017 | Mar 31, 2017 | $3.08B | – |
| Q4 FY2016 | Dec 31, 2016 | $1.50B | – |
| Q3 FY2016 | Sep 30, 2016 | $3.43B | – |
See a number that looks wrong?